Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Cathy Bradley

Concepts (501)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Employment
41
2025
188
10.380
Why?
Neoplasms
72
2025
2887
9.510
Why?
Medicaid
37
2023
466
7.600
Why?
Cancer Survivors
17
2025
331
5.150
Why?
Breast Neoplasms
49
2024
2464
5.130
Why?
Insurance Coverage
22
2024
243
4.240
Why?
Medicare
36
2025
890
3.910
Why?
Insurance, Health
20
2024
307
3.530
Why?
Cost of Illness
14
2024
322
3.170
Why?
SEER Program
22
2024
225
3.080
Why?
Poverty
13
2022
530
2.780
Why?
Medically Uninsured
12
2020
129
2.440
Why?
Colorectal Neoplasms
16
2025
849
2.330
Why?
Healthcare Disparities
14
2020
736
2.330
Why?
United States
97
2025
16051
2.260
Why?
Uterine Cervical Neoplasms
7
2020
270
2.220
Why?
Health Services Accessibility
18
2024
1104
2.180
Why?
Survivors
17
2022
520
2.070
Why?
Early Detection of Cancer
10
2024
469
2.050
Why?
Medical Oncology
6
2024
332
1.950
Why?
Registries
33
2026
2398
1.830
Why?
Health Benefit Plans, Employee
5
2022
26
1.810
Why?
Antineoplastic Agents
9
2025
2202
1.750
Why?
Health Care Costs
14
2024
427
1.750
Why?
Humans
205
2026
145305
1.730
Why?
Carcinoma, Non-Small-Cell Lung
6
2025
1183
1.720
Why?
Survivorship
4
2022
55
1.560
Why?
Drug Costs
4
2025
116
1.500
Why?
Health Care Reform
4
2021
110
1.430
Why?
Lung Neoplasms
11
2025
2652
1.410
Why?
Caregivers
6
2023
1056
1.390
Why?
Aged
77
2025
26001
1.270
Why?
Female
130
2026
78605
1.240
Why?
Colonic Neoplasms
5
2016
260
1.240
Why?
Policy
4
2024
147
1.170
Why?
Prostatic Neoplasms
11
2022
979
1.170
Why?
Research
6
2022
431
1.160
Why?
Middle Aged
79
2026
36021
1.160
Why?
Mental Health
4
2023
793
1.150
Why?
Socioeconomic Factors
20
2022
1327
1.140
Why?
Michigan
24
2015
136
1.140
Why?
Prescription Drugs
2
2023
111
1.090
Why?
Income
8
2024
202
1.080
Why?
Efficiency
7
2016
104
1.050
Why?
Neoplasm Staging
17
2022
1470
1.040
Why?
Male
99
2026
72628
1.030
Why?
Health Status
10
2013
837
1.000
Why?
Aged, 80 and over
37
2025
8295
0.970
Why?
Medical Record Linkage
2
2021
68
0.970
Why?
Health Status Disparities
2
2023
322
0.960
Why?
Papanicolaou Test
2
2017
35
0.950
Why?
Adult
69
2026
40627
0.950
Why?
Primary Health Care
6
2023
1737
0.880
Why?
Motivation
2
2020
612
0.860
Why?
Occupational Medicine
1
2024
14
0.840
Why?
Safety-net Providers
3
2017
131
0.840
Why?
Cancer Care Facilities
4
2024
48
0.840
Why?
Medicare Part C
1
2025
31
0.830
Why?
Patient Acceptance of Health Care
4
2018
887
0.810
Why?
Eligibility Determination
5
2018
72
0.790
Why?
Comorbidity
12
2019
1661
0.780
Why?
Communication
3
2024
973
0.770
Why?
Quality of Life
8
2023
3197
0.770
Why?
Colonoscopy
4
2019
261
0.750
Why?
Health Expenditures
8
2023
194
0.750
Why?
Return to Work
4
2022
22
0.740
Why?
Absenteeism
4
2013
53
0.730
Why?
Virginia
7
2018
55
0.700
Why?
Mass Screening
10
2022
1357
0.700
Why?
Occupational Health
1
2024
210
0.680
Why?
Focus Groups
1
2024
579
0.680
Why?
Workplace
4
2021
274
0.660
Why?
Medication Adherence
2
2023
541
0.660
Why?
Young Adult
27
2026
14163
0.660
Why?
Mammography
5
2024
166
0.640
Why?
Cost Sharing
1
2020
20
0.620
Why?
Models, Economic
2
2011
62
0.610
Why?
Health Equity
1
2022
129
0.610
Why?
Information Dissemination
1
2022
223
0.600
Why?
Public Health
1
2024
566
0.590
Why?
Chemotherapy, Adjuvant
7
2023
425
0.580
Why?
Perioperative Care
1
2021
232
0.580
Why?
Health Planning Guidelines
1
2018
24
0.570
Why?
Preventive Health Services
5
2023
154
0.570
Why?
Retirement
5
2022
35
0.570
Why?
Health Facilities
1
2019
86
0.550
Why?
Spouses
3
2017
108
0.550
Why?
Cost-Benefit Analysis
9
2024
639
0.540
Why?
Quality Indicators, Health Care
1
2020
336
0.540
Why?
Diagnostic Imaging
1
2020
342
0.540
Why?
Survival Analysis
10
2019
1386
0.530
Why?
Reimbursement, Incentive
1
2017
42
0.510
Why?
Healthy People Programs
1
2016
7
0.490
Why?
Occupational Health Services
2
2016
37
0.480
Why?
Bevacizumab
1
2017
168
0.470
Why?
Logistic Models
13
2023
2119
0.470
Why?
Job Satisfaction
3
2013
243
0.470
Why?
Job Description
2
2013
12
0.470
Why?
Triple Negative Breast Neoplasms
3
2023
216
0.460
Why?
Massachusetts
4
2021
180
0.460
Why?
Hematopoietic Stem Cell Transplantation
1
2021
677
0.450
Why?
Outpatients
1
2019
443
0.450
Why?
Length of Stay
6
2012
1342
0.440
Why?
Chronic Pain
1
2019
292
0.440
Why?
State Government
3
2014
46
0.430
Why?
Rectal Neoplasms
1
2016
158
0.430
Why?
Fee-for-Service Plans
4
2023
99
0.430
Why?
Vaginal Smears
1
2014
55
0.420
Why?
Nursing Homes
4
2013
172
0.420
Why?
Longitudinal Studies
11
2022
2959
0.410
Why?
Health Services Research
4
2010
396
0.410
Why?
Mouth Neoplasms
3
2019
91
0.410
Why?
Emergency Treatment
1
2015
124
0.400
Why?
General Practice
1
2014
32
0.400
Why?
Databases, Factual
8
2026
1488
0.400
Why?
Risk Factors
16
2026
10816
0.400
Why?
Sick Leave
2
2019
16
0.390
Why?
Delivery of Health Care
5
2024
947
0.390
Why?
Cross-Sectional Studies
13
2023
5883
0.380
Why?
Sickness Impact Profile
1
2013
62
0.380
Why?
Behavioral Risk Factor Surveillance System
4
2017
59
0.370
Why?
Health Personnel
3
2022
748
0.370
Why?
Diabetes Mellitus, Type 2
4
2015
2592
0.370
Why?
Insurance Claim Review
2
2010
83
0.360
Why?
Marital Status
3
2007
46
0.360
Why?
Value of Life
2
2008
19
0.360
Why?
Homes for the Aged
2
2013
32
0.360
Why?
Work
3
2010
23
0.360
Why?
Cohort Studies
10
2025
5982
0.350
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2023
1962
0.350
Why?
Age Factors
11
2022
3339
0.350
Why?
Colorado
5
2026
4579
0.350
Why?
Survival Rate
7
2020
2100
0.340
Why?
Neoplasm Metastasis
3
2020
697
0.330
Why?
Health Services
1
2012
115
0.330
Why?
Periodicals as Topic
2
2023
204
0.330
Why?
Patient Protection and Affordable Care Act
3
2024
103
0.330
Why?
Hypoglycemia
1
2015
477
0.320
Why?
Quality Improvement
2
2018
1296
0.320
Why?
Physician Self-Referral
1
2010
1
0.320
Why?
Social Class
4
2022
268
0.320
Why?
Surgical Procedures, Operative
2
2012
271
0.320
Why?
Intestinal Perforation
3
2016
44
0.310
Why?
Models, Econometric
6
2017
34
0.300
Why?
Financing, Personal
2
2019
27
0.300
Why?
Biomedical Research
2
2020
713
0.300
Why?
Data Collection
3
2014
635
0.300
Why?
Carcinoma, Squamous Cell
3
2019
643
0.300
Why?
Waiting Lists
1
2011
263
0.300
Why?
Astrocytoma
1
2010
129
0.290
Why?
Radiation Oncology
1
2010
89
0.290
Why?
Costs and Cost Analysis
2
2022
220
0.290
Why?
Physicians
1
2018
950
0.290
Why?
Recovery of Function
1
2013
714
0.290
Why?
Gastrointestinal Hemorrhage
3
2016
137
0.290
Why?
Administration, Oral
2
2023
848
0.280
Why?
Surveys and Questionnaires
12
2018
6079
0.280
Why?
Dentists
1
2008
21
0.280
Why?
Persuasive Communication
1
2008
14
0.280
Why?
Dental Care
1
2008
26
0.280
Why?
Life Expectancy
1
2008
72
0.270
Why?
Oropharyngeal Neoplasms
2
2018
55
0.270
Why?
Multivariate Analysis
9
2019
1540
0.270
Why?
Propensity Score
1
2010
370
0.270
Why?
Odds Ratio
9
2014
1077
0.270
Why?
Stroke
3
2026
1260
0.250
Why?
HIV Infections
2
2022
3158
0.250
Why?
Pneumonectomy
1
2008
169
0.250
Why?
Patient Education as Topic
1
2011
782
0.240
Why?
Confidence Intervals
4
2013
333
0.240
Why?
Likelihood Functions
5
2021
143
0.240
Why?
Women, Working
2
2002
12
0.230
Why?
Quality-Adjusted Life Years
4
2017
122
0.230
Why?
Time Factors
11
2013
7186
0.230
Why?
Online Systems
1
2005
21
0.230
Why?
Depression
4
2021
1561
0.230
Why?
Sex Factors
7
2026
2115
0.230
Why?
Forecasting
6
2020
392
0.220
Why?
Colonic Diseases
2
2016
34
0.220
Why?
Disability Evaluation
1
2007
310
0.220
Why?
Cost Savings
2
2018
86
0.220
Why?
Adolescent
15
2026
22507
0.220
Why?
Treatment Outcome
12
2019
11731
0.220
Why?
Education, Medical, Graduate
1
2010
560
0.220
Why?
Myocardial Infarction
3
2023
1211
0.210
Why?
Cross Infection
2
2017
263
0.210
Why?
Health Services Needs and Demand
3
2017
281
0.210
Why?
Anxiety
3
2021
1113
0.210
Why?
Leukemia, Myeloid, Acute
1
2011
684
0.200
Why?
Methicillin-Resistant Staphylococcus aureus
2
2017
250
0.200
Why?
Referral and Consultation
1
2010
853
0.200
Why?
Models, Statistical
4
2017
682
0.200
Why?
Probability
5
2023
312
0.200
Why?
Needs Assessment
2
2024
406
0.200
Why?
Head and Neck Neoplasms
2
2019
562
0.200
Why?
Hospitals, Public
1
2023
30
0.200
Why?
Time-to-Treatment
1
2025
245
0.190
Why?
Physician-Patient Relations
1
2008
588
0.190
Why?
Community-Based Participatory Research
1
2024
166
0.190
Why?
Substance-Related Disorders
3
1997
1094
0.190
Why?
Economics, Medical
1
2022
6
0.190
Why?
Staphylococcal Infections
2
2017
391
0.190
Why?
Hormones
1
2023
134
0.190
Why?
Carcinoma
2
2017
228
0.180
Why?
Age Distribution
4
2020
403
0.180
Why?
Migraine Disorders
1
2024
112
0.180
Why?
Salaries and Fringe Benefits
1
2002
60
0.180
Why?
Colonic Polyps
2
2014
85
0.180
Why?
Health Behavior
2
2019
789
0.180
Why?
Risk Assessment
6
2022
3686
0.180
Why?
Bisexuality
1
2022
39
0.180
Why?
Smoking
2
2019
1472
0.180
Why?
Hospital Charges
3
2003
46
0.180
Why?
Food Supply
1
2022
90
0.180
Why?
Proportional Hazards Models
5
2019
1328
0.180
Why?
Ambulatory Care Facilities
1
2024
266
0.170
Why?
Incidence
5
2022
2892
0.170
Why?
Insulin, Isophane
1
2001
22
0.170
Why?
Evidence-Based Medicine
2
2016
737
0.170
Why?
Hypoglycemic Agents
3
2018
1391
0.170
Why?
Analgesics, Opioid
2
2021
1145
0.170
Why?
Intensive Care Units
2
2017
916
0.160
Why?
Neoplasm Recurrence, Local
3
2021
1148
0.160
Why?
Brain Neoplasms
1
2010
1327
0.160
Why?
Kentucky
1
2020
41
0.160
Why?
Retrospective Studies
13
2024
17149
0.160
Why?
Homosexuality, Male
1
2022
223
0.160
Why?
Internet
1
2005
701
0.160
Why?
Exercise
3
2023
2206
0.160
Why?
Decision Making
2
2005
980
0.160
Why?
Delayed Diagnosis
1
2020
98
0.160
Why?
Sample Size
1
2000
123
0.150
Why?
Population Surveillance
2
2022
485
0.150
Why?
California
2
2018
475
0.150
Why?
Regression Analysis
5
2021
1003
0.150
Why?
Hospitalization
5
2016
2443
0.150
Why?
Carrier State
2
2017
79
0.150
Why?
Benzodiazepines
1
2021
168
0.150
Why?
Stress, Psychological
2
2021
1153
0.150
Why?
Language Development Disorders
1
2019
40
0.150
Why?
Ownership
2
2010
115
0.140
Why?
Infection Control
2
2017
173
0.140
Why?
Feasibility Studies
1
2023
1103
0.140
Why?
Patient Selection
3
2010
726
0.140
Why?
Anthracyclines
3
2023
47
0.140
Why?
Los Angeles
2
2015
76
0.140
Why?
National Cancer Institute (U.S.)
3
2023
52
0.140
Why?
Patient Care Team
1
2024
692
0.140
Why?
Child
7
2024
22712
0.140
Why?
Diabetes Mellitus
3
2018
1098
0.140
Why?
Exercise Therapy
1
2023
474
0.140
Why?
Taxoids
3
2023
116
0.140
Why?
Activities of Daily Living
2
2010
441
0.140
Why?
Cetuximab
1
2018
111
0.140
Why?
Carboplatin
1
2018
161
0.140
Why?
Radiotherapy, Adjuvant
1
2019
223
0.140
Why?
Cancer Pain
1
2018
37
0.140
Why?
Hyperlipidemias
1
2019
122
0.140
Why?
Ireland
2
2016
32
0.140
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2019
439
0.130
Why?
Research Design
4
2007
1137
0.130
Why?
Infant, Newborn
4
2020
6456
0.130
Why?
Unemployment
2
2009
42
0.130
Why?
Managed Care Programs
1
2018
140
0.130
Why?
Hypertension
2
2024
1266
0.130
Why?
Financing, Government
1
2017
53
0.130
Why?
Accidental Falls
1
2020
222
0.130
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2017
61
0.130
Why?
Public Health Practice
1
2017
63
0.130
Why?
Combined Modality Therapy
4
2019
1268
0.130
Why?
Patient Rights
2
2019
11
0.130
Why?
Hospital Costs
2
2011
124
0.130
Why?
Attitude to Health
3
2019
436
0.130
Why?
Inpatients
2
2012
551
0.120
Why?
Psychiatric Department, Hospital
1
1996
12
0.120
Why?
Patient Discharge
1
2023
987
0.120
Why?
Cisplatin
1
2018
336
0.120
Why?
Drug Therapy
1
2017
80
0.120
Why?
Sex Distribution
3
2020
386
0.120
Why?
Child Behavior
1
1998
236
0.120
Why?
Heart Failure
2
2023
2331
0.120
Why?
Self Efficacy
1
2019
414
0.120
Why?
Lymph Nodes
1
2019
502
0.120
Why?
Language
1
2019
323
0.120
Why?
Ambulatory Surgical Procedures
1
2016
80
0.110
Why?
Smoking Cessation
1
2019
439
0.110
Why?
Neonatal Abstinence Syndrome
1
1996
27
0.110
Why?
Clinical Competence
2
2014
1247
0.110
Why?
Colorectal Surgery
1
2015
27
0.110
Why?
Patient Admission
1
1997
218
0.110
Why?
Minority Groups
1
2017
283
0.110
Why?
Residence Characteristics
2
2008
378
0.110
Why?
Metformin
1
2018
320
0.110
Why?
Child, Preschool
4
2020
11863
0.110
Why?
Case-Control Studies
4
2024
3613
0.110
Why?
Mastectomy, Segmental
3
2009
108
0.100
Why?
Follow-Up Studies
6
2019
5431
0.100
Why?
Antineoplastic Agents, Hormonal
1
2015
198
0.100
Why?
National Health Programs
1
2014
23
0.100
Why?
Child Development
1
2019
490
0.100
Why?
Pennsylvania
2
2024
138
0.100
Why?
Patient Satisfaction
2
2013
706
0.100
Why?
Autism Spectrum Disorder
1
2019
412
0.100
Why?
Systems Integration
1
2013
36
0.100
Why?
Infant
3
2020
10101
0.100
Why?
Bridged-Ring Compounds
2
2023
31
0.100
Why?
Health Status Indicators
1
2014
166
0.100
Why?
Cerebrovascular Disorders
1
2014
105
0.100
Why?
Computer Simulation
2
2023
1026
0.100
Why?
Helping Behavior
1
2013
20
0.100
Why?
Kaplan-Meier Estimate
3
2021
967
0.100
Why?
Pilot Projects
3
2021
1894
0.090
Why?
Quality of Health Care
2
2008
696
0.090
Why?
Medical Audit
1
2013
77
0.090
Why?
Occupations
1
2012
51
0.090
Why?
Mandatory Programs
1
2012
16
0.090
Why?
Intensive Care Units, Neonatal
1
1996
280
0.090
Why?
Insurance, Pharmaceutical Services
1
2012
24
0.090
Why?
Pregnancy, Unwanted
1
2012
15
0.090
Why?
Maryland
3
1997
66
0.090
Why?
Life Tables
2
2008
21
0.090
Why?
Prospective Studies
3
2017
8011
0.090
Why?
Cost Control
1
2012
37
0.090
Why?
Cause of Death
1
2014
474
0.090
Why?
Goals
2
2023
184
0.090
Why?
Self Disclosure
1
2011
62
0.090
Why?
Community Health Services
1
2013
234
0.090
Why?
Contraceptive Agents, Female
1
2012
80
0.080
Why?
Educational Status
1
2013
467
0.080
Why?
Contraception Behavior
1
2012
108
0.080
Why?
Retreatment
1
2011
77
0.080
Why?
Sepsis
1
2017
641
0.080
Why?
Video Recording
1
2011
214
0.080
Why?
Mental Disorders
2
1997
1173
0.080
Why?
Economics, Nursing
1
2010
1
0.080
Why?
Mastectomy
1
2011
162
0.080
Why?
Interinstitutional Relations
1
2010
53
0.080
Why?
Insulin
1
2001
2507
0.080
Why?
Stress, Physiological
1
2013
453
0.080
Why?
Access to Information
1
2010
48
0.080
Why?
Guideline Adherence
1
2014
589
0.080
Why?
Pregnancy Complications
1
1996
592
0.080
Why?
Reproducibility of Results
3
2010
3419
0.080
Why?
Sentinel Surveillance
1
2009
46
0.080
Why?
Bone Marrow Transplantation
1
2011
294
0.080
Why?
Consumer Behavior
1
1990
70
0.080
Why?
Standard of Care
1
2010
80
0.080
Why?
Insurance Claim Reporting
1
2009
26
0.070
Why?
Ohio
1
2009
145
0.070
Why?
Occult Blood
1
2009
40
0.070
Why?
Private Sector
1
2009
50
0.070
Why?
Women's Health
2
2012
310
0.070
Why?
Models, Theoretical
1
2013
582
0.070
Why?
Comparative Effectiveness Research
1
2010
170
0.070
Why?
Physical Exertion
1
2010
207
0.070
Why?
Gastrointestinal Neoplasms
1
2009
70
0.070
Why?
Bias
1
2010
202
0.070
Why?
Linear Models
1
2011
854
0.070
Why?
Home Nursing
1
2008
23
0.070
Why?
Reimbursement Mechanisms
1
2009
80
0.070
Why?
Severity of Illness Index
2
2026
2926
0.070
Why?
Sex Characteristics
2
2022
791
0.070
Why?
Prevalence
2
2020
2838
0.070
Why?
Psychometrics
1
2013
736
0.070
Why?
Education, Professional
1
2008
18
0.070
Why?
Health Care Surveys
1
2010
539
0.070
Why?
Data Interpretation, Statistical
1
2010
372
0.070
Why?
Pain
2
2010
784
0.070
Why?
Radiotherapy
1
2008
206
0.070
Why?
Self Care
1
2010
389
0.060
Why?
Chi-Square Distribution
1
2008
529
0.060
Why?
Pulmonary Disease, Chronic Obstructive
1
2014
923
0.060
Why?
Leukemia
1
2008
245
0.060
Why?
Cognition Disorders
1
2010
538
0.060
Why?
National Institutes of Health (U.S.)
1
2006
143
0.060
Why?
Lung Diseases
1
2012
790
0.060
Why?
Charities
1
2005
13
0.060
Why?
Empirical Research
1
2005
21
0.050
Why?
Hospice Care
1
2007
220
0.050
Why?
Diabetes Mellitus, Type 1
1
2001
3906
0.050
Why?
Diagnosis-Related Groups
1
2003
35
0.050
Why?
Randomized Controlled Trials as Topic
1
2010
1747
0.050
Why?
Florida
2
2014
117
0.050
Why?
Resource Allocation
1
2003
53
0.050
Why?
Pandemics
2
2022
1698
0.050
Why?
Health Surveys
2
2007
518
0.050
Why?
Causality
1
2023
126
0.050
Why?
Social Security
1
2002
5
0.050
Why?
Selection Bias
1
2002
38
0.050
Why?
Markov Chains
2
2017
130
0.050
Why?
Motor Activity
1
2007
725
0.050
Why?
Sampling Studies
1
2002
99
0.050
Why?
Mastectomy, Radical
1
2001
4
0.040
Why?
Interviews as Topic
1
2005
907
0.040
Why?
Diagnostic Tests, Routine
1
2002
108
0.040
Why?
Insulin, Long-Acting
1
2001
65
0.040
Why?
Family Characteristics
1
2002
197
0.040
Why?
Insulin Glargine
1
2001
88
0.040
Why?
Arrhythmias, Cardiac
1
2023
361
0.040
Why?
Normal Distribution
1
2000
22
0.040
Why?
Drug Evaluation
1
2000
79
0.040
Why?
Pancreatic Neoplasms
1
2008
928
0.040
Why?
Diffusion of Innovation
1
2001
98
0.040
Why?
Nursing Research
1
2000
53
0.040
Why?
Presenteeism
1
2019
6
0.040
Why?
Clinical Trials as Topic
1
2004
1063
0.040
Why?
Palliative Care
1
2007
1012
0.040
Why?
Etidronic Acid
1
1998
3
0.040
Why?
Alendronate
1
1998
14
0.040
Why?
Federal Government
1
2018
23
0.040
Why?
Osteoporosis, Postmenopausal
1
1998
40
0.030
Why?
Informed Consent
1
2000
198
0.030
Why?
Receptors, Estrogen
1
2021
458
0.030
Why?
Spinal Fractures
1
1998
73
0.030
Why?
Controlled Before-After Studies
1
2017
15
0.030
Why?
Smoking Prevention
1
1998
166
0.030
Why?
Lymph Node Excision
1
2019
174
0.030
Why?
Lymphatic Metastasis
1
2019
335
0.030
Why?
Estrogen Replacement Therapy
1
1998
145
0.030
Why?
Tennessee
1
2017
54
0.030
Why?
Hyperglycemia
1
2001
376
0.030
Why?
Puberty
1
1998
140
0.030
Why?
Ecosystem
1
2022
590
0.030
Why?
Diagnosis, Dual (Psychiatry)
1
1997
40
0.030
Why?
Patient Isolation
1
2017
20
0.030
Why?
Chemoradiotherapy
1
2018
239
0.030
Why?
Biopsy, Needle
1
2017
183
0.030
Why?
Utilization Review
1
1996
39
0.030
Why?
Arizona
1
1996
81
0.030
Why?
Drug Administration Schedule
1
2018
783
0.030
Why?
Bacteriological Techniques
1
2017
68
0.030
Why?
Patient Dropouts
1
1997
65
0.030
Why?
Schools
1
2000
453
0.030
Why?
Anticholesteremic Agents
1
2018
154
0.030
Why?
Catheter-Related Infections
1
2017
95
0.030
Why?
Epidemiological Monitoring
1
2017
69
0.030
Why?
Dyslipidemias
1
2018
182
0.030
Why?
Health Policy
1
2019
401
0.030
Why?
Alzheimer Disease
1
2002
622
0.030
Why?
Hospitals, Community
1
1996
65
0.030
Why?
Obstetric Labor, Premature
1
1996
39
0.030
Why?
Neoplasm Invasiveness
1
2017
510
0.030
Why?
Health Resources
2
2009
131
0.030
Why?
Antihypertensive Agents
1
2018
513
0.030
Why?
Protoporphyrins
1
1993
14
0.030
Why?
Telemedicine
1
2023
957
0.030
Why?
Learning Curve
1
2014
70
0.020
Why?
Acute Disease
1
1996
1031
0.020
Why?
Lead
1
1993
70
0.020
Why?
Immunohistochemistry
1
2017
1718
0.020
Why?
Sensitivity and Specificity
3
2009
1992
0.020
Why?
Calcium
1
1998
1185
0.020
Why?
Opioid-Related Disorders
1
2021
602
0.020
Why?
Community Participation
1
2013
132
0.020
Why?
Societies, Medical
1
2016
893
0.020
Why?
Risk
1
2014
912
0.020
Why?
Gastroenterology
1
2014
190
0.020
Why?
General Surgery
1
2014
208
0.020
Why?
Pregnancy
2
2012
7208
0.020
Why?
Hepatitis B
1
1991
66
0.020
Why?
Work Capacity Evaluation
1
2010
11
0.020
Why?
Cooperative Behavior
1
2013
467
0.020
Why?
Contraception
1
2012
170
0.020
Why?
Prognosis
1
2019
4310
0.020
Why?
Budgets
1
2009
14
0.020
Why?
Sigmoidoscopy
1
2009
15
0.020
Why?
Leadership
1
2013
410
0.020
Why?
Task Performance and Analysis
1
2010
198
0.020
Why?
Meta-Analysis as Topic
1
2009
174
0.020
Why?
Prostatectomy
1
2009
94
0.020
Why?
Ambulatory Care
1
2013
603
0.020
Why?
Age of Onset
1
2009
551
0.020
Why?
Occupational Exposure
1
1991
354
0.020
Why?
Psychology
1
2008
88
0.020
Why?
Demography
1
2008
288
0.020
Why?
Lifting
1
2006
4
0.010
Why?
Least-Squares Analysis
1
2006
76
0.010
Why?
Illinois
1
2006
47
0.010
Why?
Mortality
1
2008
376
0.010
Why?
Telephone
1
2007
176
0.010
Why?
Body Weight
1
1990
980
0.010
Why?
Patient Compliance
1
2009
589
0.010
Why?
Prejudice
1
2006
60
0.010
Why?
Myocardial Revascularization
1
2003
85
0.010
Why?
Burnout, Professional
1
2010
487
0.010
Why?
Statistics, Nonparametric
1
2003
427
0.010
Why?
Vaccination
1
1991
1428
0.010
Why?
Behavior
1
2002
91
0.010
Why?
Episode of Care
1
2001
7
0.010
Why?
Decision Trees
1
2001
82
0.010
Why?
Drug Prescriptions
1
2002
286
0.010
Why?
Cardiac Catheterization
1
2003
561
0.010
Why?
Reoperation
1
2001
631
0.010
Why?
Neuropsychological Tests
1
2002
1138
0.010
Why?
Drug Therapy, Combination
1
1998
1048
0.010
Why?
Estrogens
1
1998
381
0.010
Why?
Estradiol
1
1998
533
0.010
Why?
Lead Poisoning
1
1993
17
0.010
Why?
Reference Values
1
1993
798
0.010
Why?
ROC Curve
1
1993
615
0.010
Why?
Program Evaluation
1
1991
949
0.000
Why?
Bradley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)